Citadel Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,224	Closed	-$7.88K	–	16078
2022 Q4	$7.88K	Buy	11,224 +6,912	+160%	+$11.2K	﹤0.01%	13789
2022 Q3	$12K	Buy	+4,312	New	+$16.3K	﹤0.01%	12240
2022 Q2	–	Sell	-7,037	Closed	-$50K	–	14862
2022 Q1	$50K	Buy	+7,037	New	+$40.9K	﹤0.01%	12791
2021 Q3	–	Sell	-5,207	Closed	-$97K	–	15198
2021 Q2	$97K	Buy	+5,207	New	+$97.1K	﹤0.01%	12946
2019 Q1	–	Sell	-179	Closed	-$6K	–	10177
2018 Q4	$6K	Sell	179 -42	-19%	-$3.54K	﹤0.01%	8979
2018 Q3	$34K	Buy	+221	New	+$32.7K	﹤0.01%	8896
2017 Q3	–	Hold	0	–	–	–	8342
2017 Q2	–	Hold	0	–	–	–	8384
2017 Q1	–	Sell	-122	Closed	-$25K	–	8339
2016 Q4	$25K	Buy	+122	New	+$27.7K	﹤0.01%	7036
2016 Q3	–	Sell	-100	Closed	-$30K	–	8129
2016 Q2	$30K	Buy	+100	New	+$35.2K	﹤0.01%	6524